Angela R. Omilian, Ph.D.

Indiana University, Bloomington, Bloomington, IN, United States 
"Angela Omilian"
Mean distance: 18 (cluster 10)


Sign in to add mentor
Michael Lynch grad student 2006 Indiana University
 (Features of Daphnia genome evolution.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Abdou Y, Attwood K, Cheng TD, et al. (2020) Racial differences in CD8 T cell infiltration in breast tumors from Black and White women. Breast Cancer Research : Bcr. 22: 62
Omilian AR, Wei L, Hong CC, et al. (2020) Somatic mutations of triple-negative breast cancer: a comparison between Black and White women. Breast Cancer Research and Treatment
Llanos AAM, Lin Y, Chen W, et al. (2020) Immunohistochemical analysis of adipokine and adipokine receptor expression in the breast tumor microenvironment: associations of lower leptin receptor expression with estrogen receptor-negative status and triple-negative subtype. Breast Cancer Research : Bcr. 22: 18
Bandera EV, Demissie K, Qin B, et al. (2020) The Women's Circle of Health Follow-Up Study: a population-based longitudinal study of Black breast cancer survivors in New Jersey. Journal of Cancer Survivorship : Research and Practice
Abdou Y, Attwood K, Yao S, et al. (2020) Role of CD8+ T-cell infiltration in breast tumors of Black women compared to White women. Journal of Clinical Oncology. 38
Yao S, Cheng T, Elkhanany A, et al. (2020) Abstract IA26: Breast tumor microenvironment in black women: A distinct signature of CD8+ T-cell exhaustion Cancer Epidemiology, Biomarkers & Prevention
Abdou Y, Yao S, Attwood K, et al. (2020) Abstract P2-10-02: Racial differences in infiltration of CD8+ T-cells in breast tumors of Black and White women Cancer Research. 80
Cheng TD, Yao S, Omilian AR, et al. (2019) FOXA1 protein expression in ER+ and ER- breast cancer in relation to parity and breastfeeding in Black and White women. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology
Bunch B, Krishnan N, Greenspan RD, et al. (2019) TAp73 expression and P1 promoter methylation, a potential marker for chemoresponsiveness to cisplatin therapy and survival in muscle-invasive bladder cancer (MIBC). Cell Cycle (Georgetown, Tex.). 1-12
Mukhopadhyay UK, Oturkar CC, Adams C, et al. (2019) TP53 Status as a Determinant of Pro- versus Anti-tumorigenic Effects of Estrogen Receptor-beta in Breast Cancer. Journal of the National Cancer Institute
See more...